QQQ   352.71 (+1.12%)
AAPL   179.86 (+1.15%)
MSFT   325.17 (+0.55%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.08 (+3.79%)
NVDA   386.95 (+3.26%)
NIO   7.73 (-0.39%)
BABA   86.45 (+1.37%)
AMD   121.01 (+2.70%)
T   16.04 (-0.37%)
F   13.58 (-0.07%)
MU   65.19 (-2.79%)
CGC   0.71 (-2.10%)
GE   106.68 (+0.57%)
DIS   92.45 (-0.08%)
AMC   4.72 (-0.21%)
PFE   39.01 (+0.31%)
PYPL   64.31 (+0.42%)
NFLX   405.90 (+1.53%)
QQQ   352.71 (+1.12%)
AAPL   179.86 (+1.15%)
MSFT   325.17 (+0.55%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.08 (+3.79%)
NVDA   386.95 (+3.26%)
NIO   7.73 (-0.39%)
BABA   86.45 (+1.37%)
AMD   121.01 (+2.70%)
T   16.04 (-0.37%)
F   13.58 (-0.07%)
MU   65.19 (-2.79%)
CGC   0.71 (-2.10%)
GE   106.68 (+0.57%)
DIS   92.45 (-0.08%)
AMC   4.72 (-0.21%)
PFE   39.01 (+0.31%)
PYPL   64.31 (+0.42%)
NFLX   405.90 (+1.53%)
QQQ   352.71 (+1.12%)
AAPL   179.86 (+1.15%)
MSFT   325.17 (+0.55%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.08 (+3.79%)
NVDA   386.95 (+3.26%)
NIO   7.73 (-0.39%)
BABA   86.45 (+1.37%)
AMD   121.01 (+2.70%)
T   16.04 (-0.37%)
F   13.58 (-0.07%)
MU   65.19 (-2.79%)
CGC   0.71 (-2.10%)
GE   106.68 (+0.57%)
DIS   92.45 (-0.08%)
AMC   4.72 (-0.21%)
PFE   39.01 (+0.31%)
PYPL   64.31 (+0.42%)
NFLX   405.90 (+1.53%)
QQQ   352.71 (+1.12%)
AAPL   179.86 (+1.15%)
MSFT   325.17 (+0.55%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.08 (+3.79%)
NVDA   386.95 (+3.26%)
NIO   7.73 (-0.39%)
BABA   86.45 (+1.37%)
AMD   121.01 (+2.70%)
T   16.04 (-0.37%)
F   13.58 (-0.07%)
MU   65.19 (-2.79%)
CGC   0.71 (-2.10%)
GE   106.68 (+0.57%)
DIS   92.45 (-0.08%)
AMC   4.72 (-0.21%)
PFE   39.01 (+0.31%)
PYPL   64.31 (+0.42%)
NFLX   405.90 (+1.53%)
OTCMKTS:SZLSF

StageZero Life Sciences (SZLSF) Stock Forecast, Price & News

$0.03
-0.02 (-40.00%)
(As of 06/7/2023 ET)
Compare
Today's Range
$0.03
$0.04
50-Day Range
$0.03
$0.08
52-Week Range
$0.03
$0.10
Volume
3,575 shs
Average Volume
1,184 shs
Market Capitalization
$3.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SZLSF stock logo

About StageZero Life Sciences (OTCMKTS:SZLSF) Stock

StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall on February 20, 1997 and is headquartered in Richmond Hill, Canada.

Receive SZLSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

SZLSF Stock News Headlines

Dually-Listed Healthcare Stock Rallies On Q1 Results
The 4th Military Revolution is Happening
. There have been 3 military revolutions in the past 100 years. The first was when the tank was invented in 1915. The second was the nuclear bomb in 1945. The third was the "smart bomb" in 1991. Amid the turmoil, there will be many losers. Click here to see how to win instead >>>
[BREAKING] New "Living Software" to Revolutionize Warfare
This breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>
StageZero Life Sciences CFO resigns
StageZero Life Sciences Launches AVRT(TM) in the UK
See More Headlines

SZLSF Price History

SZLSF Company Calendar

Last Earnings
3/31/2023
Today
6/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:SZLSF
Employees
51
Year Founded
N/A

Profitability

Net Income
$-11,410,000.00
Net Margins
-388.59%
Pretax Margin
-91.19%

Debt

Sales & Book Value

Annual Sales
$3.80 million
Book Value
$0.03 per share

Miscellaneous

Free Float
102,786,000
Market Cap
$3.16 million
Optionable
Not Optionable
Beta
0.57

Key Executives

  • James R. Howard-Tripp
    Executive Chairman & Chief Executive Officer
  • Rebecca Greco
    Head-Investor Relations













SZLSF Stock - Frequently Asked Questions

How have SZLSF shares performed in 2023?

StageZero Life Sciences' stock was trading at $0.0443 on January 1st, 2023. Since then, SZLSF shares have decreased by 32.3% and is now trading at $0.03.
View the best growth stocks for 2023 here
.

How were StageZero Life Sciences' earnings last quarter?

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) posted its earnings results on Friday, March, 31st. The company reported ($0.09) EPS for the quarter. The business earned $0.68 million during the quarter. StageZero Life Sciences had a negative net margin of 388.59% and a negative trailing twelve-month return on equity of 877.87%.

What is StageZero Life Sciences' stock symbol?

StageZero Life Sciences trades on the OTCMKTS under the ticker symbol "SZLSF."

How do I buy shares of StageZero Life Sciences?

Shares of SZLSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is StageZero Life Sciences' stock price today?

One share of SZLSF stock can currently be purchased for approximately $0.03.

How much money does StageZero Life Sciences make?

StageZero Life Sciences (OTCMKTS:SZLSF) has a market capitalization of $3.16 million and generates $3.80 million in revenue each year. The company earns $-11,410,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis.

How can I contact StageZero Life Sciences?

StageZero Life Sciences' mailing address is 70 East Beaver Creek Road Unit 30, Richmond Hill A6, L4B 3B2. The official website for the company is www.stagezerolifesciences.com. The company can be reached via phone at (855) 420-7140, via email at rgreco@stagezerols.com, or via fax at 905-209-2031.

This page (OTCMKTS:SZLSF) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -